Your search returned 2 results.

Results
	1.	Omacetaxine mepesuccinate for patients with accelerated phase chronic myeloid leukemia with resistance or intolerance to two or more tyrosine kinase inhibitors. [electronic resource] by Nicolini, Franck E Khoury, H Jean Akard, Luke Rea, Delphine Kantarjian, Hagop Baccarani, Michele Leonoudakis, Janis Craig, Adam Benichou, Annie-Claude Cortes, Jorge Producer: 20140707 In: Haematologica vol. 98 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Subcutaneous omacetaxine mepesuccinate in patients with chronic-phase chronic myeloid leukemia previously treated with 2 or more tyrosine kinase inhibitors including imatinib. [electronic resource] by Cortes, Jorge E Nicolini, Franck E Wetzler, Meir Lipton, Jeffrey H Akard, Luke Craig, Adam Nanda, Nisha Benichou, Annie-Claude Leonoudakis, Janis Khoury, H Jean Hochhaus, Andreas Baccarani, Michele Kantarjian, Hagop M Producer: 20140408 In: Clinical lymphoma, myeloma & leukemia vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search